| 000 | 02570cam a2200397Ii 4500 | ||
|---|---|---|---|
| 001 | 95808 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112722.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170417s2017 sz a ob 000 0 eng d | ||
| 020 |
_a3319524445 _q(electronic bk.) |
||
| 020 |
_a9783319524443 _q(electronic bk.) |
||
| 020 | _z3319524429 | ||
| 020 |
_z9783319524429 _q(print) |
||
| 040 |
_aN$T _cN$T _dGW5XE _dEBLCP _dN$T _dYDX _dOCLCF _dUAB _dOCLCO _dESU _dAZU _dUPM _dOCLCO _dMERER _dOCLCO _dOCLCQ _dVT2 _dOTZ _dOCLCQ _dIOG _dOCLCO _dJG0 _dOCLCO _dU3W _dOCLCO _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRM315 _b.N487 2017 EB |
|
| 245 | 0 | 0 |
_aNeuropharmacology of new psychoactive substances (NPS) : _bthe science behind the headlines _cMichael H. Baumann, Richard A. Glennon, Jenny L. Wiley, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c2017. |
|
| 300 |
_a1 recurso en línea (viii, 380 páginas) _bilustraciones (algunas a color) |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 |
_aCurrent topics in behavioral neurosciences _x1866-3370 _vvolume 32 |
|
| 500 |
_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International |
||
| 504 | _aIncluye referencias bibliográficas | ||
| 520 | 3 | _aDesigner drugs, or new psychoactive substances (NPS), are synthetic chemicals that mimic the effects of classic drugs of abuse. There has been an alarming worldwide increase in the abuse of NPS in recent years. NPS are cheap, easy to obtain, and often legally available. In this volume, leading experts summarize the latest studies regarding the molecular mechanisms of action, behavioral effects, and adverse consequences of popular NPS. Specific chapters clarify the differences between various types of NPS, namely: stimulants, cannabinoids and hallucinogens. Thus, this volume broadens our understanding of NPS and provides insight into the rapidly evolving "new drug" phenomenon. | |
| 650 | 7 |
_aNeurofarmacología _2embne _0(OCoLC)fst01036458 _0 _9154004 |
|
| 700 | 1 |
_aBaumann, Michael H., _eeditor literario |
|
| 700 | 1 |
_aGlennon, Richard A., _d1945- _eeditor literario |
|
| 700 | 1 |
_aWiley, Jenny L., _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-52444-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER_2017C | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95808 _d95808 _x1 |
||